GGrantIndex
Sort

78,016 grants matching breast cancer

Dynamic Imaging of EMT in the Breast Cancer Microenvironment

$668,764
Christopher H Contag · Stanford University · R01 · FY2013 · CA

Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer

$668,650
Ming You · Methodist Hospital Research Institute · R01 · FY2022 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$668,635
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$668,635
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Clinical Protocol and Data Management (Core 018)

$668,602
Elizabeth C Dees · Univ Of North Carolina Chapel Hill · P30 · FY2019 · CA

Abbreviated Non-Contrast-Enhanced MRI for Breast Cancer Screening

$668,498
Brian Andrew Hargreaves · Stanford University · R01 · FY2023 · CA

Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci

$668,422
Simon Andrew Gayther · Cedars-Sinai Medical Center · R01 · FY2022 · CA

Regulation and Manipulation of Innate Immunity During HIV Infection

$668,416
Jarrod Sean Johnson · University Of Utah · R56 · FY2023 · AI

INCREASING SCREENING ADHERENCE THROUGH A PHYSICIAN TRIAL

$668,378
University Of California Los Angeles · R01 · FY2001 · CA

RANK SIGNALING INHIBITORS FOR TREATING BREAST CANCER BONE METASTASIS

$668,250
University Of Alabama At Birmingham · · FY2022 · Defense Health Agency

Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1

$668,222
Jane Amanda Skok · New York University School Of Medicine · R01 · FY2024 · CA

Improving Cancer Outcomes for African-Americans

$668,211
New Hanover Regional Medical Center · U56 · FY2005 · CA

Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu

$668,144
Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2023 · CA

Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu

$668,144
Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2025 · CA

Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer

$668,132
Neil Mukund Iyengar · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy

$668,129
Richard Leo Wahl · Johns Hopkins University · U01 · FY2012 · CA

Prognostic analysis and progression modeling of basal-like breast cancer using multi-region sequencing

$668,114
Yijun Sun · State University Of New York At Buffalo · R01 · FY2023 · CA

(PQC2)High-content Pathology with Confocal Microscope Arrays

$668,080
Christopher H Contag · Stanford University · R01 · FY2013 · CA

Genome-wide association study of breast cancer in high-risk women

$668,080
Christopher Alan Haiman · University Of Southern California · R01 · FY2013 · CA

Consent in Genetic Research: An International Trial

$668,063
Case Western Reserve University · R01 · FY2003 · HG

Secondary Prevention through Surveillance and Intervention

$668,058
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2017 · CA

Biological Functions of Chromosomal Proteins

$668,049
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)

$668,037
Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis

$668,028
Rebecca A Shelby · Duke University · R01 · FY2020 · CA

A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors

$668,024
Patricia A. Ganz · University Of California Los Angeles · R01 · FY2016 · CA